MedPath

BIAL - PORTELA & CA., S.A.

🇵🇹Portugal
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

147

Active:143
Completed:1

Trial Phases

1 Phases

Phase 1:95

Drug Approvals

23

CIMA_AEMPS:20
EMA:3

Drug Approvals

Ontilyv

Authorization Status
Lapsed
Approval Date
Feb 21, 2022
EMA

Ongentys

Authorization Status
Authorised
Approval Date
Jun 24, 2016
EMA

Zebinix

Authorization Status
Authorised
Approval Date
Apr 21, 2009
EMA

Clinical Trials

Distribution across different clinical trial phases (95 trials with phase data)• Click on a phase to view related trials

Phase 1
95 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.